BMPR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.933000E-01
Normal-vs-Stage2
9.614000E-01
Normal-vs-Stage3
2.586600E-01
Normal-vs-Stage4
3.490400E-01
Stage1-vs-Stage2
6.886800E-01
Stage1-vs-Stage3
1.886630E-01
Stage1-vs-Stage4
1.170820E-01
Stage2-vs-Stage3
2.054800E-01
Stage2-vs-Stage4
7.508300E-02
Stage3-vs-Stage4
1.091580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.408400E-01
Normal-vs-AfricanAmerican
5.960800E-01
Normal-vs-Asian
8.885200E-01
Caucasian-vs-AfricanAmerican
2.520600E-01
Caucasian-vs-Asian
8.617400E-01
AfricanAmerican-vs-Asian
3.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.343400E-01
Normal-vs-Female
9.059200E-01
Male-vs-Female
4.362600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.806600E-01
Normal-vs-Age(41-60Yrs)
5.676600E-01
Normal-vs-Age(61-80Yrs)
8.133000E-01
Normal-vs-Age(81-100Yrs)
2.208400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.840200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.889200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.657190E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.043300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.374770E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.470400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.044000E-01
Normal-vs-Daily Drinker
4.242000E-01
Normal-vs-Weekly Drinker
8.664400E-01
Normal-vs-Occasional Drinker
6.503000E-01
Normal-vs-Social Drinker
8.868000E-01
Non Drinker-vs-Daily Drinker
5.499200E-01
Non Drinker-vs-Weekly Drinker
5.343800E-01
Non Drinker-vs-Occasional Drinker
4.700300E-02
Non Drinker-vs-Social Drinker
3.451800E-01
Daily Drinker-vs-Weekly Drinker
2.769600E-01
Daily Drinker-vs-Occasional Drinker
2.172400E-02
Daily Drinker-vs-Social Drinker
2.119400E-01
Weekly Drinker-vs-Occasional Drinker
2.657800E-01
Weekly Drinker-vs-Social Drinker
6.234600E-01
Occasional Drinker-vs-Social Drinker
6.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.307410E-01
Normal-vs-Grade 2
1.268420E-02
Normal-vs-Grade 3
2.630300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.325600E-02
Grade 1-vs-Grade 3
9.503700E-02
Grade 1-vs-Grade 4
1.307410E-01
Grade 2-vs-Grade 3
8.780800E-01
Grade 2-vs-Grade 4
1.268420E-02
Grade 3-vs-Grade 4
2.630300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.285000E-01
Normal-vs-NonDiabetic
9.066400E-01
Diabetic-vs-NonDiabetic
7.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.128800E-01
Normal-vs-NoPancreatitis
9.449800E-01
Pancreatitis-vs-NoPancreatitis
4.076600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.489000E-01
Normal-vs-N1
9.167800E-01
N0-vs-N1
2.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.007200E-01
Normal-vs-TP53-NonMutant
7.155600E-01
TP53-Mutant-vs-TP53-NonMutant
1.059150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
